{"slideshow_credits": null, "snippet": "Under the deal, Salix will merge with Cosmo Technologies, the Irish unit of Cosmo Pharmaceuticals of Italy, in exchange for a stake of more than 20 percent in the combined company.", "abstract": "Under the deal, Salix will merge with Cosmo Technologies, the Irish unit of Cosmo Pharmaceuticals of Italy, in exchange for a stake of more than 20 percent in the combined company.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Chad", "role": "reported", "lastname": "BRAY", "rank": 1, "organization": ""}], "original": "By CHAD BRAY"}, "web_url": "http://dealbook.nytimes.com/2014/07/09/salix-pharmaceuticals-to-buy-irish-company-and-reincorporate-overseas/", "lead_paragraph": null, "headline": {"main": "Salix Pharmaceuticals to Buy Irish Company and Reincorporate Overseas", "print_headline": "Inversion Deal", "kicker": "DealBook"}, "_id": "53bd6be138f0d84a131d8912", "word_count": "613", "multimedia": [], "pub_date": "2014-07-09T12:03:02Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Salix Pharmaceuticals Ltd", "rank": "2"}, {"name": "organizations", "value": "Cosmo Technologies Ltd", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "3"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "2"}, {"name": "subject", "value": "Corporate Taxes", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}